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PURPOSE. To investigate the anti-inflammatory effect of topical
application of Curcuma longa (C. longa) and Berberis
aristata (B. aristata) aqueous extracts on experimental uveitis
in the rabbit.
METHODS. Anterior uveitis was induced in rabbits by intravitreal
injection of lipopolysaccharide from Escherichia coli after pre-
treatment with C. longa and B. aristata aqueous extracts.
Subsequently, the anti-inflammatory activity of C. longa and B.
aristata was evaluated by grading the clinical signs and his-
topathologic changes and estimating the inflammatory cell
count, protein, and TNF- levels in the aqueous humor.
RESULTS. The anterior segment inflammation in the control
group was significantly higher than in both the extract-treated
groups, as observed by clinical and histopathologic grading.
The inflammatory cell count in the control group was 30.75 
7.33  105 cells/mL, whereas it was 2.39  0.59  105 (P 
0.001 vs. control) and 11.56  2.44  105 (P  0.001 vs.
control) cells/mL in the C. longa– and B. aristata–treated
groups, respectively. The protein content of the aqueous hu-
mor was 18.14  4.98, 3.16  0.55 (P  0.001 vs. control),
and 8.24  1.42 (P  0.01 vs. control) mg/mL in the control,
C. longa–, and B. aristata–treated groups, respectively. The
aqueous TNF- level in the control group was 976.29  66.38
pg/mL and was 311.96  28.50 (P  0.0001 vs. control) and
654.09  47.66 (P  0.001vs. control) pg/mL in the C. longa–
and B. aristata–treated groups, respectively.
CONCLUSIONS. Topical instillation of aqueous extracts of C.
longa and B. aristata showed potent anti-inflammatory activity
against endotoxin-induced uveitis in rabbits. (Invest Ophthal-
mol Vis Sci. 2008;49:4036–4040) DOI:10.1167/iovs.07-1186
The animal model of endotoxin-induced uveitis has oftenbeen used to represent acute anterior uveitis in humans.
Lipopolysaccharide (LPS), a glycolipid from the outer cell
membranes of Gram-negative bacteria is a proinflammatory
component and is used to induce uveitis in animals by a
systemic or ocular route.1,2 Exposure to LPS induces expres-
sion of various mediators of inflammation such as tumor ne-
crosis factor (TNF)- and other cytokines.3–5 Increased ex-
pression of inflammatory mediators contributes to the devel-
opment of anterior uveitis, with the breakdown of the blood–
ocular barrier leading to infiltration of the aqueous humor with
inflammatory cells and the leakage of protein.6 Experimental
uveitis peaks at 24 hours after LPS injection and gradually
subsides over the next 24 hours.
Curcuma longa (C. longa) and Berberis aristata (B.
aristata) are two among the many herbs that have been widely
used in traditional medicine for centuries. Turmeric, the pow-
dered form of the rhizome of C. longa is rich in curcuminoids.
Among the curcuminoids, curcumin is the major phenolic
component in the rhizomes of C. longa. The roots of B.
aristata contain significant amounts of the isoquinoline alka-
loid berberine. Both the herbs are well known for their anti-
inflammatory activity. The aqueous extract of the roots of B.
aristata (500–1000 mg/kg) was found to have a significant
anti-inflammatory effect in rats with carrageenan-induced paw
edema; the effect was comparable to that of 10 mg diclofenac
sodium.7 The alkaloid berberine from B. aristata has antibac-
terial effects and has been found to be useful in cases of
trachoma.8 Berberine has also been found to be effective in
experimental herpetic uveitis.9 Berberine was also shown to
abolish acetaldehyde-induced NF-B activity and cytokine pro-
duction in HepG2 cells in a dose-dependent manner.10 Extracts
of C. longa have also exhibited anti-inflammatory effects in
standard animal models used for testing anti-inflammatory ac-
tivity.11–13 Curcumin, a major chemical constituent of C. longa
was found to inhibit leukotriene formation in rat peritoneal
polymorphonuclear neutrophils.14 Possible benefits of oral
curcumin supplementation have been observed in cases of
chronic anterior uveitis.15 As in the case of berberine, cur-
cumin exhibits an ability to suppress NF-B activity and cyto-
kine production in experimental acute liver injury.16 In view of
the potent anti-inflammatory activity of C. longa and B.
aristata, the present study was designed to investigate the
effect of topical application of their aqueous extracts in endo-
toxin-induced uveitis.
MATERIALS AND METHODS
All procedures were conducted according to the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research. New Zealand
White rabbits weighing 2.5 to 3 kg were obtained from the animal
house facility at Delhi Institute of Pharmaceutical Sciences and Re-
search. The aqueous extracts of C. longa (rhizome) and B. aristata
(roots) were provided by Promed Exports Pvt Ltd. (New Delhi, India)
and were authenticated by high-performance thin-layer chromatogra-
phy (HPTLC) fingerprinting. The powdered extracts were dissolved in
0.25% hydroxy propyl methylcellulose and filtered with 0.22-m filters
(Millipore, Billerica, MA). The filtrate was stored at 4°C in sterile
sealed vials until further use.
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Study Design
The rabbits were divided into three groups of four rabbits each (eight
eyes). The rabbits in groups 1 and 2 were topically instilled with 0.1%
C. longa and 2% B. aristata aqueous extract, respectively, while group
3 (control group) received the vehicle. All instillations were performed
three times a day for 3 days before induction of experimental uveitis
and continued for 3 days after induction. Twenty-four hours after the
induction of experimental uveitis, aqueous humor sampling was per-
formed for cell count, protein, and TNF- estimation. The rabbits were
reexamined 72 hours after the endotoxin injection for clinical signs of
uveitis and then were killed and the eyes enucleated for histopatho-
logic examination.
Rabbit Model of Experimental Uveitis
The endotoxin used to induce uveitis was lipopolysaccharide (LPS)
from Escherichia coli (Sigma-Aldrich, St. Louis, MO). The endotoxin
was injected intravitreally in both eyes. One drop of proparacaine HCl
(0.5%) solution was used for topical anesthesia. After the upper lid was
retracted, 20 L (100 ng) of the endotoxin solution was injected
intravitreally at the 12 o’clock position, 3 to 4 mm posterior to the
limbus with a 30-gauge needle. Preliminary dose–response studies
were undertaken, and 100 ng was found to be the optimal dose for
induction of uveitis in rabbits. Subsequently, the eyes were examined
for clinical grading, and aqueous humor was tapped for inflammatory
cell count, protein, and TNF- estimation. The person performing
aqueous humor sampling, cell count, protein, and TNF- estimation
was masked to the treatment given. The rabbits were killed after
clinical assessment for signs of uveitis, 72 hours after experimental
induction of uveitis.
Clinical Grading of Ocular Inflammation
The clinical signs of ocular inflammation were graded on a scale of 0 to 4
according to the scoring system described by Ruiz-Moreno et al.17 The
grading scale was as follows: no inflammatory reaction, 0; discrete inflam-
matory reaction, 1; moderate dilation of the iris and conjunctival vessels,
2; intense iridal hyperemia, with flare in the anterior chamber, 3; and the
same clinical signs as grade 3 plus the presence of fibrinoid exudation in
the pupillary area, with intense flare in the anterior chamber, 4.
The grading of clinical signs of uveitis was performed at 24 and 72
hours after intravitreal injection of endotoxin.
Aqueous Humor Sampling
The animals were anesthetized with ketamine (20–40 mg/kg) and
xylazine (1–2 mg/kg) by intramuscular injection in the hind limb.
Proparacaine HCl (0.5%) solution was used topically to supplement the
general anesthesia. During preliminary studies, attempts at aqueous
humor (AH) sampling under topical anesthesia were found to be very
painful and therefore further AH sampling was performed under gen-
eral anesthesia. AH (150–200 L) was aspirated from the anterior
chamber with a 30-gauge disposable insulin syringe, and care was
taken not to injure the iris or lens during the procedure. Each aqueous
humor sample was diluted 50-fold with PBS.
Total Cell Count
The AH sample was suspended in an equal volume of Turk’s stain solution
and cell counting was performed on a hemocytometer under light micro-
scope. The cell count per field (each field considered equal to 0.1 mL) was
estimated as an average of counts in four fields per sample. Subsequently,
the number of cells per milliliter of AH was calculated.
Total Protein Estimation
Protein estimation in AH samples was performed according to the
method described by Lowry et al.18 Briefly, 10 L of AH sample was
diluted with 990 L of 1 N NaOH and reacted with 5 mL of copper
reagent. After 10 minutes, 0.5 mL of Folin’s reagent was added and
vortexed, and the samples were kept in the dark for 30 minutes.
Absorbance was recorded with a spectrophotometer at 620 nm. Bo-
vine serum albumin (BSA) was taken as a protein standard to calculate
the protein content of the sample. All estimations were performed in
duplicate.
The cell count and protein estimation were performed on the day
of AH sampling.
FIGURE 1. Clinical signs of anterior
uveitis in control and treated groups.
(A) Just before intravitreal endotoxin
injection. (B) Twenty-four and (C)
72 hours after intravitreal endotoxin
injection.
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TNF- Estimation
TNF- levels in AH were estimated by using a commercially available
enzyme-linked immunosorbent assay (ELISA) kit from Diaclone (Besan-
c¸on, France), per the manufacturer’s instructions. All estimations were
performed in duplicate.
Histopathologic Examination
The rabbits’ eyes were enucleated 72 hours after intravitreal injection
of endotoxin and fixed in 10% formaldehyde. The sections (6–8 m
thick) were stained with hematoxylin and eosin, and the structures in
the immediate vicinity of endotoxin injection (i.e., anterior chamber,
posterior chamber, and ciliary body) were evaluated for severity of
vasodilatation, edema, and inflammatory cell infiltration. The inflam-
matory changes were graded on a scale of 0 to 5: none, 0; minimum,
1; discrete, 2; moderate, 3; severe, 4; and intense, 5.
RESULTS
Clinical Signs of Uveitis
The rabbits in the control group showed significantly higher
grades of ocular inflammation than did the C. longa– and B.
aristata–treated groups (Fig. 1). At 24 hours after intravitreal
injection of endotoxin, the vehicle-treated control group had a
mean score of 2.75  0.56 (range, 2–4), whereas the C. longa–
and B. aristata–treated groups showed a mean score of 1.13 
0.48 (range, 0–2) and 2.00  0.41 (range, 1–3), respectively, at
the same time point (Fig. 2). Clinical signs of uveitis observed at
72 hours after endotoxin injection are shown in Table 1.
Total Cell Count
C. longa– and B. aristata–treated groups showed a 92.24% and
62.40% inhibition of inflammatory cell infiltration, respectively,
compared with that in the control group. In the control group,
the total inflammatory cell count in the aqueous humor 24
hours after intravitreal injection of endotoxin was 30.75 
7.33  105 cells/mL (mean  SD, n  8). The rabbits pre-
treated with C. longa and B. aristata showed significantly
lower inflammatory cell counts (2.39  0.59  105 cells/mL,
P  0.001 vs. control; and 11.56  2.44  105 cells/mL, P 
0.001 vs. control) in the aqueous humor obtained at the same
time point. In addition, a significantly lower inflammatory cell
infiltration was observed in the C. longa–treated group than in
the B. aristata–treated group (P  0.001; Fig. 3).
Total Protein
Total proteins as estimated 24 hours after intravitreal injection
of endotoxin showed significantly lower values in the extract-
treated groups. In the C. longa–treated group the protein
concentration was 3.16  0.55 mg/mL compared with 8.24 
1.42 and 18.14  4.98 mg/mL in the B. aristata–treated and
control groups, respectively. The protein concentration in the
C. longa–treated group was significantly lower than in the B.
aristata–treated group (P  0.001) and control group (P 
0.001). The aqueous humor protein concentration in the B.
aristata–treated group was also significantly lower than in the
control group (P  0.01; Fig. 4).
Tumor Necrosis Factor-
Aqueous humor TNF- levels in C. longa– and B. aristata–
treated rabbits showed 68.05% and 33% lower values, respec-
tively, compared with the control. The aqueous humor TNF-
level in the control group was 976.29 66.38 pg/mL, whereas
it was 311.96  28.50 (P  0.0001 vs. control) and 654.09 
47.66 (P  0.001 vs. control) pg/mL in the C. longa– and B.
aristata–treated groups, respectively. The TNF- level in the C.
longa–treated group was significantly lower than in the B.
aristata–treated group (P  0.0001; Fig. 5).
Histopathologic Evaluation
The histopathologic examination of all eight rabbit eyes in the
control group showed severe inflammatory changes with in-
terstitial edema, vasodilatation, and extensive inflammatory
cell infiltration of the anterior chamber, posterior chamber,
and ciliary body. The mean histopathologic grade in the con-
trol group was found to be 4.38  0.41 (range, 3–5). In the C.
FIGURE 2. The effect of topical instillation of aqueous extract of C.
longa (CL; 0.1%) and B. aristata (BA; 2%) on the development of
inflammatory signs in rabbits with experimental uveitis. The grading of
clinical signs of uveitis was done 24 hours after intravitreal injection.
All data are expressed as the mean  SD. *P  0.01 vs. control; **P 
0.05 vs. control (n  8).
FIGURE 3. The effect of topical instillation of aqueous extract of C.
longa (CL; 0.1%) and B. aristata (BA; 2%) on inflammatory cell infil-
tration in rabbits with experimental uveitis. The aqueous humor was
collected 24 hours after intravitreal injection of endotoxin. All values
are expressed as the mean  SD. *P  0.001 vs. control and BA, **P 
0.05 versus control (n  8).
TABLE 1. The Histopathologic and Clinical Score of Rabbit Eyes 72
Hours after Intravitreal Injection of Endotoxin
Groups
Histopathologic
Score Clinical Score
Control 4.38  0.41 2.75  0.56
C. longa 1.13  0.54*† 0.75  0.25*†
B. aristata 2.13  0.41* 1.63  0.41‡
All values are group mean  SD.
* P  0.001 vs. control.
† P  0.05 vs. B. aristata group.
‡ P  0.01 vs. control.
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longa–treated group, only one eye was completely free of
inflammation, whereas others showed mild edema, vasodilata-
tion, and inflammatory cell infiltration, mainly in the posterior
chamber. The mean histopathologic score in the C. longa–
treated group was 1.13  0.54 (range, 0–2). In B. aristata,
seven eyes showed mild-to-moderate inflammatory changes,
one eye showed very minimal inflammatory changes, and none
was found to be completely free of inflammatory changes. The
mean histopathologic grade in B. aristata–treated group was
2.13  0.41 (range, 1–3). The statistical analysis of the his-
topathologic score showed a significantly higher degree of
inflammation in the control group than in the C. longa– and B.
aristata–treated groups (P  0.001). A significantly higher
degree of inflammation was observed in the B. aristata–treated
group than in the C. longa–treated group (P  0.05; Table 1,
Fig. 6).
DISCUSSION
The results of the present study clearly demonstrated the
protective effects of the topical application of two herbs in
endotoxin-induced uveitis. The animals in the treated groups
showed not only significantly reduced severity of clinical signs
and histopathologic changes of uveitis but also significant re-
duction in aqueous humor levels of inflammatory cells, protein
contents, and TNF- compared with the control group.
The endotoxin-induced model used in this study is not an
exact representation of clinical uveitis, but the inflammatory
response and cytokine production in response to endotoxin
closely resembles the acute phase of clinical uveitis. The en-
dotoxin-induced inflammation can be observed during antibi-
otic therapy for ocular infections. The antibiotics, while de-
stroying the bacteria, also release the LPS from their cell walls,
thereby leading to an inflammatory response. The drugs found
effective in endotoxin-induced uveitis may be effective in the
treatment of ocular and systemic Gram-negative bacterial infec-
tions.
After intravitreal injection, the strong biological activity of
the endotoxin initiates the inflammatory vascular and cellular
responses. Increased production and release of monocytes,
macrophages, and other inflammatory cells is associated with
the release of potent inflammatory mediators in the aqueous
FIGURE 5. The effect of topical instillation of aqueous extract of C.
longa (CL; 0.1%) and B. aristata (BA; 2%) on TNF- in aqueous humor
in rabbits with experimental uveitis. All values are expressed as the
mean  SD. *P  0.001 vs. control and BA; **P  0.05 vs. control (n 
8).
FIGURE 4. The effect of topical instillation of aqueous extract of C.
longa (CL; 0.1%) and B. aristata (BA; 2%) on protein concentration in
aqueous humor in rabbits with experimental uveitis. All values are
expressed as the mean SD. *P 0.001 vs. control and BA; **P 0.05
vs. control (n  8).
FIGURE 6. Micrographs of hematox-
ylin and eosin–stained sections of
rabbit eyes 72 hours after intravitreal
endotoxin injection. (A) Control
group. Extensive inflammatory cell
infiltration was seen in the posterior
chamber (PC; arrow), the anterior
chamber (AC), and the ciliary body
(CB). (B) C. longa–treated group.
Very few inflammatory cells were
seen in the PC and CB. (C) B.
aristata–treated group, with moder-
ate inflammatory cell infiltration in
the PC and mild infiltration in the CB
and AC.
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humor. One of these is TNF-, which appears to be essential in
the development of endotoxin-induced inflammation.19,20 Be-
sides the chemical mediators of inflammation, cell adhesion
molecules play a vital role in leukocyte adherence to vascular
endothelial cells during the early acute phase of inflammation
and contribute to the leakage of protein.
The drugs used in our study have demonstrated a significant
anti-inflammatory effect in other studies,7–9,11–13 including im-
provement of chronic uveitis by oral supplementation.15 The
therapeutic response to topical application of aqueous extracts
of C. longa and B. aristata has demonstrated for the first time
the possible utility of these drugs as a topical application for
the treatment of anterior uveitis. The reduced severity of in-
flammatory changes observed in histopathologic examination
and clinical manifestations in the inflamed eye was the result of
significant inhibition of vascular and cellular inflammatory re-
sponses. The release of chemical mediators of inflammation is
also suppressed secondary to inhibition of the cellular re-
sponse. The suppression of vascular and cellular inflammatory
responses by herbal extracts was evidenced by significantly
low levels of inflammatory cells, proteins, and TNF- levels in
aqueous humor of treated animals. Significantly reduced pro-
tein levels in aqueous humor also indicates a possible inhibi-
tory role of extract constituents on leukocyte adherence to the
vascular endothelium. Direct binding to LPS of some of the
extract constituents may be another mechanism of suppres-
sion of endotoxin-triggered uveitis. Inhibition of cyclooxygen-
ase (COX)-2 may also contribute to the anti-inflammatory effect
in anterior uveitis, as studies have shown selective COX 2
inhibitory activity of curcumin and berberine.21,22 Further
studies of the isolated active principle components of these
herbal extracts are warranted, to explore fully the mechanisms
of anti-inflammatory activity in endotoxin-induced uveitis.
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